Cargando…
CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer
BACKGROUND: Successful neoadjuvant chemotherapy (NACT) could improve the surgical resection rate and radical curability of patients with cervical cancer, but only a subset of patients benefits. Therefore, identifying predictive biomarkers are urgently needed. The aim of this study was to evaluate th...
Autores principales: | Lin, Yun, Li, Zhi, Liu, Mubiao, Ye, Haiyan, He, Jianhui, Chen, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277608/ https://www.ncbi.nlm.nih.gov/pubmed/33392721 http://dx.doi.org/10.1007/s00404-020-05921-8 |
Ejemplares similares
-
Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility‐Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer
por: Zusterzeel, Petra L.M., et al.
Publicado: (2020) -
Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients
por: Müller, Carolin, et al.
Publicado: (2020) -
Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
por: Müller, Carolin, et al.
Publicado: (2021) -
The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer
por: Rawert, Friederike Luise, et al.
Publicado: (2022) -
Incidence and predictors for chemotherapy modifications and their impact on the outcome of ovarian cancer patients
por: Hatsy, Sandra, et al.
Publicado: (2022)